Company research
SenesTech, Inc.
CIK 1680378Updated Sep 27, 2026
SecuritySNES · NASDAQ · equity
Historical securities (1)
SSEHW · OTC · warrant · closed Aug 14, 2023SNES price & chart
Loading TradingView…
NASDAQ:SNES on TradingView ↗About the company
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The company’s groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech’s mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
In the news
SenesTech to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025 News provided by SenesTech, Inc. Nov 03, 2025, 16:15 ET Share this article Share to X Share this article Share to X Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. ↗
Recent filings
Show 5 more recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
Results of Operations and Financial Condition
Items 2.02, 9.01
4 filing
4 filing
4 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 12,843,000Source | 3,278,000Source | 7,293,000Source | 6,782,000Source |
| Property, Plant and Equipment, NetUSD | 410,000Source | 407,000Source | 388,000Source | 294,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,575,000Source | 1,307,000Source | 5,395,000Source | 4,775,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 201,000Source | 335,000Source | 95,000Source | 113,000Source |
| Inventory, NetUSD | 994,000Source | 794,000Source | 795,000Source | 853,000Source |
| Assets, CurrentUSD | 10,061,000Source | 2,813,000Source | 6,673,000Source | 6,119,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,336,000Source | 0Source | 210,000Source | 347,000Source |
| Other Assets, NoncurrentUSD | 36,000Source | 58,000Source | 22,000Source | 22,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,275,000Source | 767,000Source | 942,000Source | 1,503,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 5,000Source | 1,000Source | 5,000Source | 1,000Source |
| Additional Paid in CapitalUSD | 152,043,000Source | 138,607,000Source | 136,259,000Source | 127,481,000Source |
| Retained Earnings (Accumulated Deficit)USD | -142,480,000Source | -136,097,000Source | -129,913,000Source | -122,203,000Source |
| Stockholders' Equity Attributable to ParentUSD | 9,568,000Source | 2,511,000Source | 6,351,000Source | 5,279,000Source |
| Liabilities and EquityUSD | 12,843,000Source | 3,278,000Source | 7,293,000Source | 6,782,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 798,000Source | 561,000Source | 786,000Source | 1,324,000Source |
| Operating Lease, Liability, CurrentUSD | 139,000Source | 0Source | 217,000Source | 180,000Source |
| Accounts Payable, CurrentUSD | 183,000Source | 215,000Source | 150,000Source | 540,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,332,000Source | — | 0Source | 179,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 383,000Source | 278,000Source | 368,000Source | 560,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 8,600,000Source | — | — | — |
| Deferred Tax Liabilities, NetUSD | 599,000Source | 0Source | 52,000Source | 86,000Source |
| Long-term Debt, Current MaturitiesUSD | — | — | — | 0Source |
| Short-term InvestmentsUSD | 994,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -6,383,000Source | -6,184,000Source | -7,710,000Source | -9,695,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 135,000Source | 156,000Source | 135,000Source | 183,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 264,000Source | 326,000Source | 555,000Source | 711,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -121,000Source | 242,000Source | -20,000Source | 42,000Source |
| Increase (Decrease) in InventoriesUSD | 200,000Source | -1,000Source | -58,000Source | -148,000Source |
| Increase (Decrease) in Accounts PayableUSD | -32,000Source | 65,000Source | -390,000Source | 206,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -5,750,000Source | -6,033,000Source | -7,566,000Source | -8,577,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,102,000Source | -56,000Source | -149,000Source | -170,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 138,000Source | 84,000Source | 149,000Source | 174,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | 0Source | 11,000Source | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 13,120,000Source | 2,001,000Source | 8,335,000Source | 4,196,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 6,268,000Source | -4,088,000Source | 620,000Source | -4,551,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 7,575,000Source | 1,307,000Source | 5,395,000Source | 4,775,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 22,000Source | 22,000Source | 4,000Source | 1,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 264,000Source | 326,000Source | 555,000Source | 711,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 8,600,000Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | 0Source | 28,000Source | 0Source | -28,000Source |
| General and Administrative ExpenseUSD | 6,195,000Source | 5,541,000Source | 7,043,000Source | 8,279,000Source |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -6,383,000Source | -6,184,000Source | -7,710,000Source | -9,695,000Source |
| Nonoperating Income (Expense)USD | 122,000Source | 65,000Source | 22,000Source | -21,000Source |
| Operating ExpensesUSD | 7,893,000Source | 7,253,000Source | 8,271,000Source | 10,138,000Source |
| Other Nonoperating Income (Expense)USD | 0Source | 31,000Source | 0Source | -26,000Source |
| Proceeds from Issuance of Common StockUSD | 2,706,000Source | 38,000Source | 5,407,000Source | 4,228,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,221,000Source | 1,857,000Source | 1,193,000Source | 1,019,000Source |
| Cost of RevenueUSD | 833,000Source | 853,000Source | 654,000Source | 555,000Source |
| Operating Income (Loss)USD | -6,505,000Source | -6,249,000Source | -7,732,000Source | -9,674,000Source |
| Other Nonoperating Income (Expense)USD | 0Source | 31,000Source | 0Source | -26,000Source |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -6,383,000Source | -6,184,000Source | -7,710,000Source | -9,695,000Source |
| Earnings Per Share, BasicUSD per share | -1.95Source | -8.86Source | -11.51Source | -15.5Source |
| Earnings Per Share, DilutedUSD per share | -1.95Source | -8.86Source | -11.51Source | -15.5Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 3,275,983Source | 697,974Source | 669,861Source | 625,401Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 3,275,983Source | 697,974Source | 669,861Source | 625,401Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 135,000Source | 156,000Source | 135,000Source | 183,000Source |
| General and Administrative ExpenseUSD | 6,195,000Source | 5,541,000Source | 7,043,000Source | 8,279,000Source |
| Gross ProfitUSD | 1,388,000Source | 1,004,000Source | 539,000Source | 464,000Source |
| Interest Expense, DebtUSD | 22,000Source | 22,000Source | 4,000Source | 2,000Source |
| Investment Income, NetUSD | 144,000Source | 56,000Source | 26,000Source | 7,000Source |
| Nonoperating Income (Expense)USD | 122,000Source | 65,000Source | 22,000Source | -21,000Source |
| Operating ExpensesUSD | 7,893,000Source | 7,253,000Source | 8,271,000Source | 10,138,000Source |
| Research and Development ExpenseUSD | 1,698,000Source | 1,712,000Source | 1,228,000Source | 1,859,000Source |